The Impact of Renal Impairment on Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With Tyrosine Kinase Inhibitors.

Haoran ZhangXingming ZhangXudong ZhuYuchao NiJindong DaiSha ZhuGuangxi SunZhipeng WangJunru ChenJinge ZhaoHao ZengZi LiPengfei Shen

Published in: Cancer control : journal of the Moffitt Cancer Center (2021)

Dynamic changes of TKI-induced RI during TKIs treatment, especially eGFR and proteinuria level, could be considered as potential biomarkers predicting survival outcomes of mRCC patients.

Keyphrases

end stage renal disease
metastatic renal cell carcinoma
newly diagnosed
tyrosine kinase
small cell lung cancer
chronic kidney disease
ejection fraction
peritoneal dialysis
epidermal growth factor receptor
high glucose
oxidative stress
drug induced
replacement therapy